Brief: Spago Nanomedical Names Candidate-Drug In Tumorad Project
Aug 24 (Reuters) - Spago Nanomedical AB (publ) SPAGO.TE :
* SPAGO NANOMEDICAL NAMES CANDIDATE-DRUG IN TUMORAD®-PROJECT
Source text for Eikon: ID:nWkr4vLk57
Further company coverage: SPAGO.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose